Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
22 hedge funds and large institutions have $155M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
27.85% more ownership
Funds ownership: 0% → 27.85% (+28%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$39.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$33.5M |
| 3 |
CA
CHI Advisors
New York
|
+$22.1M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$14.1M |
| 5 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$12.2M |
Top Sellers
FRLN Hedge Fund Activity: Q3 2020 in Review
22 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q3 2020, worth a combined $155M.
Buyers outnumbered sellers: 22 funds opened new FRLN positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Eventide Asset Management, opening a new position worth an estimated $39.2M.
- 22 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $155M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q3 2020.
- 22 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q3 2020 and 0 closed out, a net change of +22 holders.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q3 2020 was Eventide Asset Management, an estimated $39.2M added.
Based on aggregated 13F filings for Q3 2020.